Last reviewed · How we verify

NCT03747406

Erector Spinae Block and Transverse Abdominis Plane Block for Sleeve Gasterectomy

Completed NA Last updated 26 December 2019
What this trial tests

NA trial testing Erector spinae plane block in Bariatric Surgery Candidate in 66 participants. Completed in 10 July 2019.

Timeline
1 December 2018
Primary endpoint
1 June 2019
10 July 2019

Quick facts

Lead sponsorDalia Ismail
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment66
Start date1 December 2018
Primary completion1 June 2019
Estimated completion10 July 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Dalia Ismail

Who can join

Adults 18 to 59, any sex, with Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

assess the efficacy of ultrasound guided erector spinae block to decrease the requirement for analgesics after laparoscopic sleeve gastrectomy and to decrease postoperative pain scores and opioid consumption compared to subcostal transverses abdominis block.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Erector spinae plane block

Trials testing the same drug.

Other recruiting trials for Bariatric Surgery Candidate

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03747406.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing